Literature DB >> 3042995

Somatic presentations of psychiatric illness in primary care setting.

D P Goldberg1, K Bridges.   

Abstract

We have tried to describe somatisation, not as a disease, but as a common and important human mechanism involving both doctor and patient. It is the single most common reason why psychiatric illness goes undetected in general medical settings, and it often occurs in conjunction with physical disease processes. The association with dysphoric affect has been recognised at least since George Cheyne 250 years ago, and the reason for this is that both anxiety and depression serve to amplify pains. However, it seems likely that somatisation can occur in the absence of dysphoria. Once it has been established, it is easy to see how it continues: it secures advantages from spouse, family and employers; and it tends to be encouraged by doctors--who differentially reward somatic symptoms. But why does it occur in the first place? We have argued that it seems to have three functions: First, it allows people who are unsympathetic to psychological illness, or who live in cultures where mental illness is stigmatised, to nonetheless occupy the sick-role while psychologically unwell. Second, it is blame-avoiding: instead of being responsible for the mayhem, one is cast in the role of the suffering victim. Finally, by reducing blame, it appears to save patients from being as depressed as they might otherwise have been.

Entities:  

Mesh:

Year:  1988        PMID: 3042995     DOI: 10.1016/0022-3999(88)90048-7

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  53 in total

1.  The cost of somatisation among the working-age population in England for the year 2008-2009.

Authors:  Sarah L Bermingham; Alan Cohen; John Hague; Michael Parsonage
Journal:  Ment Health Fam Med       Date:  2010-06

2.  Socioeconomic differences in children's and adolescents' hospital admissions in Germany: a report based on health insurance data on selected diagnostic categories.

Authors:  S Geyer; R Peter; J Siegrist
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

3.  Bowel distress and emotional conflict.

Authors:  A Brook
Journal:  J R Soc Med       Date:  1991-01       Impact factor: 5.344

4.  Managing Medically Unexplained Symptoms in Primary Care: A Narrative Review and Treatment Recommendations.

Authors:  Sam Hubley; Lisa Uebelacker; Charles Eaton
Journal:  Am J Lifestyle Med       Date:  2014-07-02

Review 5.  Somatisation: embodying the problem.

Authors:  M Murphy
Journal:  BMJ       Date:  1989-05-20

6.  Prevalence of major depressive disorders and a validation of the Beck Depression Inventory among Nigerian adolescents.

Authors:  Abiodun O Adewuya; Bola A Ola; Olutayo O Aloba
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-04-30       Impact factor: 4.785

7.  Examination of the effects of emotional disturbance and its detection on general practice patients' satisfaction with the consultation.

Authors:  P M Wilson; F Sullivan; S Hussein; G D Smith
Journal:  Br J Gen Pract       Date:  1995-06       Impact factor: 5.386

8.  Somatization in frequent attenders of general practice.

Authors:  P J Portegijs; F G van der Horst; I M Proot; H F Kraan; N C Gunther; J A Knottnerus
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1996-01       Impact factor: 4.328

9.  Explanation and relations. How do general practitioners deal with patients with persistent medically unexplained symptoms: a focus group study.

Authors:  Tim C Olde Hartman; Lieke J Hassink-Franke; Peter L Lucassen; Karel P van Spaendonck; Chris van Weel
Journal:  BMC Fam Pract       Date:  2009-09-24       Impact factor: 2.497

10.  Severe MUPS in a sick-listed population: a cross-sectional study on prevalence, recognition, psychiatric co-morbidity and impairment.

Authors:  Rob Hoedeman; Boudien Krol; Nettie Blankenstein; Petra C Koopmans; Johan W Groothoff
Journal:  BMC Public Health       Date:  2009-12-01       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.